Biotechnology

Kelun-Biotech Approved by HKEX to Remove "B" Marker from Stock Code, Representing a New Stage of Development

CHENGDU, China, April 9, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that following an application to The Stock Exchange of Hong Kong Limited (the "Stock Exchange") pursuant to Rule 18A.12 of the Rules Governin...

2026-04-09 18:33 5294

NSG Bio and Charles River Sign Memorandum of Understanding to Strengthen Support for Biotech Innovation in Singapore

Partnership to expand ecosystem connectivity, expertise access, and enablement for life sciences companies SINGAPORE, April 9, 2026 /PRNewswire/ -- NSG Bio announced the signing of a Memorandum of Understanding (MOU) with Charles River Laboratories ("Charles River"), marking a new collaboration ...

2026-04-09 10:00 4417

First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study

SHANGHAI, April 8, 2026 /PRNewswire/ -- On March 12, 2026, the first implant of the ProStyle M® Transcatheter Mitral Valve System (ProStyle M®) was successfully completed under pure ultrasound guidance as part of its confirmatory clinical study. The device is independently developed by Kingstron...

2026-04-08 22:22 5042

Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals (Asia) Limited

* Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products * Aggregate consideration of USD250,000,000 (approximately RMB1,721,650,000), payable in three installments * Delivers near-term revenue and profitability wi...

2026-04-08 10:21 9742

LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. Market

NORWALK, Conn., April 8, 2026 /PRNewswire/ -- LBB Specialties (LBBS), a North American distributor ofspecialty chemicals and ingredients providing...

2026-04-08 03:49 3635

Live Cell Observation System Selected for NASA-Supported Project Heading to the International Space Station

Nikon Contributes to Research on the Effects of Microgravity in Drug Discovery TOKYO, April 7, 2026 /PRNewswire/ -- Nikon Corporation (Nikon) is pleased to announce that the live cell observation system developed by Nikon and its U.S.-based subsidiary Nikon Instruments Inc. (NII) has been selecte...

2026-04-07 21:41 4838

Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development

-Fixed-dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head study. The fixed dose combination had excellent oral bioavailability, drug exposure and a half-lif...

2026-04-07 19:00 6747

Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

MELBOURNE, Australia and INDIANAPOLIS, April 7, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a market update on its commercial and operational performance for the quarter ended March 31, 2026 (Q1 2026). Q1 2026 Highlights * Q1 2026 unaudited ...

2026-04-07 06:57 6692

NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 6, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-04-06 21:11

Telix Appoints David Gill as Non-Executive Director

MELBOURNE, Australia and INDIANAPOLIS, April 2, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the appointment of David Gill as a Non-Executive Director (NED), as part of Board expansion and succession planning. The appointment is effective May...

2026-04-02 06:59 5256

NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development

PRINCETON, N.J. and TOKYO, April 1, 2026 /PRNewswire/ -- NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ("Aji Bio‑Pharma"), a leading provider of biopharmaceutical manufacturing services and platform technologies...

2026-04-01 07:00 4455

3SBio Announces 2025 Annual Results: Dual Engines of Innovative R&D and Global Collaboration Propel Revenue Past RMB 10 Billion Milestone

SHANGHAI, March 31, 2026 /PRNewswire/ -- 3SBio Inc. (01530.HK ) today released its 2025 annual results announcement. Fueled by the dual core engines of breakthroughs in innovative R&D and strategic global collaboration, the company delivered a high-quality performance with bot...

2026-03-31 20:13 6527

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

TAMPA, Fla., March 31, 2026 /PRNewswire/ -- Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of the world's largest randomised controlled trial of a Sirolimus-coa...

2026-03-31 16:27 3710

DNV SELECTED TO CERTIFY CLASS D DEVICES FOR LEADING U.S. MANUFACTURER UNDER EU IVDR

DNV supports the manufacturer's transition to new regulation with its digital certification platform and transparent, predictable project management. OSLO, Norway, March 31, 2026 /PRNewswire/ -- DNV, a designated Notified Body for the European Union's In Vitro Diagnostic Regulation (IVDR) and Med...

2026-03-31 15:00 4396

NYSE Content Update: Koppers to Ring Closing Bell for 20th Listing Anniversary

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 30, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...

2026-03-30 21:08 5988

CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"

* Korea–Thailand spine experts jointly lead advanced training on endoscopic spine surgery and lateral lumbar interbody fusion techniques * Hands-on experience with Korean spine medical devices lays the foundation for advancing Asia's spine education hub SEOUL, South Korea and BANGKOK, March 3...

2026-03-30 20:00 4253

Qyuns Therapeutics-B (02509) 2025 Revenue Surges Over 4-Fold; Adjusted Profit Reaches Approximately RMB356 Million, Turning a Profit Year-on-Year

TAIZHOU, China, March 30, 2026 /PRNewswire/ -- Qyuns Therapeutics-B (02509) announced its 2025 annual results. Revenue amounted to approximately RMB807 million, representing a 4.08-fold year-on-year increase. Gross profit reached approximately RMB714 million, a 6.75-fold increase year-on-year. Pr...

2026-03-30 12:39 8036

Internationally Acclaimed Forensic Scientist Dr. Henry C. Lee Dies, Leaving Remarkable Legacy

WEST HAVEN, Conn., March 28, 2026 /PRNewswire/ -- World-renowned forensic scientist Dr. Henry C. Lee passed away peacefully on Friday, March 27, at his home in Henderson, Nevada, displaying remarkable strength, grace and resilience during a brief illness. He was 87 years old. His passing was anno...

2026-03-28 06:24 5172

Alphamab Oncology Reports Full Year 2025 Financial Results and Business Highlights

SUZHOU, China, March 26, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2025 and highlighted recent business progress. Key Highlights * KN026 (Anbenitamab) achieved robust PFS and OS benefits in second- or third-lin...

2026-03-26 13:13 7128

ScaleUp Bio Announces Fusionopolis Ventures Joining ADM as Shareholder

The partnership supports ScaleUp Bio's next phase of growth as a precision fermentation CDMO in Asia. SINGAPORE, March 26, 2026 /PRNewswire/ -- ScaleUp Bio Pte. Ltd. ("ScaleUp Bio ") today announced that Fusionopolis Ventures Pte. Ltd. ("FVPL"), a subsidiary of Economic Development Innovations Si...

2026-03-26 11:00 4342
1 ... 3456789 ... 185